These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2414201)

  • 21. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of self-reactive T cells in the donor-derived T cells but not in the host-derived T cells in fully allogeneic radiation chimeras. Mls-reactive T cells in allogeneic radiation chimeras.
    Ogimoto M; Yoshikai Y; Matsuzaki G; Ohga S; Matsumoto K; Nomoto K
    Thymus; 1991 Feb; 17(1):11-22. PubMed ID: 1901675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restricted antibody formation to sheep erythrocytes of allogeneic bone marrow chimeras histoincompatible at the K end of the H-2 complex.
    Onoé K; Yasumizu R; Oh-Ishi T; Kakinuma M; Good RA; Morikawa K
    J Exp Med; 1981 Apr; 153(4):1009-14. PubMed ID: 7019375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
    Ozawa H; Iwaguchi T; Kataoka T
    J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant MLR but not CTL responses against recipient antigens generated in T cells from bone marrow chimeras recovered from acute GVHD.
    Morohashi T; Ogasawara K; Kitaichi N; Iwabuchi K; Onoé K
    Bone Marrow Transplant; 2000 Nov; 26(10):1069-76. PubMed ID: 11108305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro.
    Johnson BD; Hanke CA; Becker EE; Truitt RL
    Cell Immunol; 1998 Nov; 189(2):149-59. PubMed ID: 9790729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
    Ogasawara M; Iwabuchi K; Good RA; Onoe K
    J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of an antigen-specific H-2-restricted cell-free products(s) made by "I-J-" Ly-2 cells (Ly-2 TsF) that suppresses Ly-2 cell-depleted spleen cell activity.
    Yamauchi K; Murphy D; Cantor H; Gershon RK
    Eur J Immunol; 1981 Nov; 11(11):913-8. PubMed ID: 6173229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feedback regulation of immune suppression by a suppressor factor.
    Ikezawa Z; Arden B; Nagy ZA; Klein J
    Eur J Immunol; 1984 Aug; 14(8):681-6. PubMed ID: 6205879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
    Budhecha S; Hamilton BL
    J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on proliferative responses to host Ia antigens in allogeneic bone marrow chimera in mice: sequential analysis of the reactivity and characterization of the cells involved in the responses.
    Iwabuchi K; Ogasawara K; Ogasawara M; Yasumizu R; Noguchi M; Geng L; Fujita M; Good RA; Onoé K
    J Immunol; 1987 Jan; 138(1):18-25. PubMed ID: 2946776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B cell-deprived mice lack functional expression of certain T suppressor cell subsets.
    Flood PM; Janeway CA; Gershon RK
    J Mol Cell Immunol; 1984; 1(3):167-76. PubMed ID: 6242856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell specificity in twice-irradiated F1----parent bone marrow chimeras: failure to detect a role for immigrant marrow-derived cells in imprinting intrathymic H-2 restriction.
    Ron Y; Lo D; Sprent J
    J Immunol; 1986 Sep; 137(6):1764-71. PubMed ID: 2943799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
    Tomita Y; Khan A; Sykes M
    J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.
    Deepe GS; Watson SR; Bullock WE
    J Immunol; 1984 Apr; 132(4):2064-71. PubMed ID: 6230399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotype-like suppression of T cell-mediated immunity in vivo. I. Delayed-type hypersensitivity specificity of T cell suppression induced by antigen-binding T cell factors that initiate contact sensitivity.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1554-63. PubMed ID: 2419404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotype-like suppression of T cell-mediated immunity in vivo. II. Suppression of the early component of contact sensitivity by a Ly-2+ T cell-derived suppressor factor that binds to contact sensitivity-initiating, antigen-specific, Ly-1+ T cell-derived factors that are of different antigen specificities.
    Ptak W; Bereta M; Ptak M; Askenase PW
    J Immunol; 1986 Mar; 136(5):1564-70. PubMed ID: 2419405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.